文献速递免疫规划卫生政策与健康促进

欧洲国家COVID-19疫苗接受度的条件性

Conditionality of COVID-19 vaccine acceptance in European countries.
PubMed 文献 · Vaccine · 2022-02-01

2020年12月欧洲疫苗推广前,在比利时、法国、德国、意大利、西班牙、瑞典和乌克兰对7000名18-65岁受访者进行在线横断面调查。56.9%的受访者愿意接受COVID-19疫苗,19.0%不愿意,24.1%不知道或不愿说;各国接受比例在44%(法国)至66%(意大利)之间。开放文本回复显示受访者表达了对疫苗安全性和对当局不信任的条件性担忧。

要点

  • 56.9%的受访者愿意接受COVID-19疫苗,19.0%不愿意,24.1%不知道或不愿说。
  • 各国接受比例在44%(法国)至66%(意大利)之间。
  • 开放回复显示受访者对疫苗安全性和当局不信任存在条件性担忧。

核心结论

  • 研究强调了疫苗条件性的动态变化以及安全担忧的持续存在。

研究设计与样本

  • 在线横断面调查于2020年12月欧洲疫苗推广前进行,纳入比利时、法国、德国、意大利、西班牙、瑞典和乌克兰的7000名18-65岁受访者。
  • 调查包含开放式文本框以更全面解释回复。

主要发现

  • 总体中,56.9%的受访者愿意接受COVID-19疫苗,19.0%不愿意,24.1%不知道或不愿说。
  • 按国家划分,受访者愿意接受COVID-19疫苗的比例在44%(法国)至66%(意大利)之间。
  • 受访者在开放回复中表达条件性,提出对疫苗安全性和对当局不信任的担忧。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The COVID-19 vaccine rollout has offered a powerful preventive measure to help control SARS-CoV-2 transmission. Nevertheless, long-standing public hesitation around vaccines heightened concerns that vaccine coverage would not achieve desired public health impacts, particularly in light of more contagious variants. This cross-sectional survey was conducted online just before the European vaccine rollout in December 2020 among 7000 respondents (aged 18-65) in Belgium, France, Germany, Italy, Spain, Sweden, and Ukraine. The survey included open text boxes for fuller explanation of responses. Overall, 56.9% of respondents would accept a COVID-19 vaccine, 19.0% would not, and 24.1% did not know or preferred not to say. By country, between 44% (France) and 66% (Italy) of respondents would accept a COVID-19 vaccine. Respondents expressed conditionality in open responses, voicing concerns about vaccine safety and mistrust of authorities. We highlight lessons learned about the dynamism of vaccine conditionality and persistence of safety concerns.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Heyerdahl LW, Vray M, Lana B, et al. Conditionality of COVID-19 vaccine acceptance in European countries. Vaccine. 2022. PMID: 35125225. doi:10.1016/j.vaccine.2022.01.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。